Get the Stockscreener App
1.32
5.60%
0.07
Pepgen Inc stock is traded at $1.32, with a volume of 241.01K.
It is up +5.60% in the last 24 hours and down -5.71% over the past month.
PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics to transform the treatment of severe neuromuscular and neurologic diseases. The company has developed its Enhanced Delivery Oligonucleotide platform to improve the uptake and activity of conjugated oligonucleotide therapeutics. Its EDO peptides are engineered to optimize tissue penetration, cellular uptake, and nuclear delivery, and in preclinical studies, it is observed their ability to transport oligonucleotides into a broad range of target tissues, including smooth, skeletal, and cardiac muscle and the central nervous system. Its pipeline products are; PGN-EDO51, PGN-EDODM1, and others including PGN-EDO53 and PGN-EDO45.
See More
Previous Close:
$1.25
Open:
$1.27
24h Volume:
241.01K
Relative Volume:
0.91
Market Cap:
$43.30M
Revenue:
-
Net Income/Loss:
$-87.23M
P/E Ratio:
-0.4444
EPS:
-2.97
Net Cash Flow:
$-82.77M
1W Performance:
+2.33%
1M Performance:
-5.71%
6M Performance:
-3.65%
1Y Performance:
-86.41%
1-Day Range:
$1.25
$1.35
1-Week Range:
$1.20
$1.35
52-Week Range:
$0.8801
$10.14
Pepgen Inc Stock (PEPG) Company Profile
Name
Pepgen Inc
Sector
Industry
Phone
703-456-8000
Address
1 MARINA PARK DRIVE, SUITE 900, BOSTON
Compare PEPG with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PEPG
Pepgen Inc
|
1.32 | 42.64M | 0 | -87.23M | -82.77M | -2.97 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.12 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
589.48 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.38 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
660.00 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
313.67 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Pepgen Inc Stock (PEPG) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-16-24 | Downgrade | BofA Securities | Neutral → Underperform |
| Jul-31-24 | Downgrade | BofA Securities | Buy → Neutral |
| Dec-21-22 | Initiated | H.C. Wainwright | Buy |
Pepgen Inc Stock (PEPG) Latest News
How to recover losses in PepGen Inc. stockJuly 2025 Market Mood & High Yield Equity Trading Tips - Newser
How to read the order book for PepGen Inc.Quarterly Investment Review & Weekly Watchlist of Top Performers - Newser
Is PepGen Inc. showing signs of accumulationPortfolio Update Summary & Proven Capital Preservation Methods - Newser
What MACD and RSI say about PepGen Inc.July 2025 Price Swings & Capital Efficient Trade Techniques - Newser
What MACD signals say about PepGen Inc.July 2025 News Drivers & Low Drawdown Momentum Trade Ideas - Newser
Applying Elliott Wave Theory to PepGen Inc.2025 Buyback Activity & Fast Gain Swing Alerts - Newser
Institutional scanner results for PepGen Inc.Portfolio Update Report & Weekly Setup with ROI Potential - Newser
Key resistance and support levels for PepGen Inc.July 2025 Action & Risk Controlled Stock Alerts - Newser
How to use Fibonacci retracement on PepGen Inc.2025 Market Outlook & Verified Swing Trading Watchlist - Newser
PepGen Inc. recovery potential after sell offMarket Performance Report & High Accuracy Trade Alerts - Newser
Is PepGen Inc. forming a reversal pattern2025 Volatility Report & Growth-Oriented Investment Plans - Newser
How to manage a losing position in PepGen Inc.July 2025 Trade Ideas & Smart Swing Trading Techniques - Newser
What’s next for PepGen Inc. stock priceWeekly Trade Recap & Weekly Breakout Watchlists - Newser
Analyzing net buyer seller activity in PepGen Inc.Bond Market & Real-Time Stock Entry Alerts - Newser
Is PepGen Inc. stock reversal real or fake2025 EndofYear Setup & Safe Swing Trade Setups - Newser
Can PepGen Inc. recover in the next quarterPortfolio Gains Report & Proven Capital Preservation Methods - Newser
What Fibonacci levels say about PepGen Inc. reboundWeekly Investment Summary & Fast Exit and Entry Trade Guides - Newser
Live market analysis of PepGen Inc.Market Sentiment Review & Safe Capital Growth Stock Tips - Newser
AI Trend Models Suggest Bounce for PepGen Inc.Buy Signal & Community Consensus Trade Signals - metal.it
Price momentum metrics for PepGen Inc. explainedMarket Movers & Accurate Buy Signal Notifications - Newser
Should I add PepGen Inc. stock to my portfolio2025 Growth vs Value & Fast Gain Swing Alerts - thegnnews.com
Exit strategy if you’re trapped in PepGen Inc.Trade Performance Summary & Safe Swing Trade Setups - Newser
Why PepGen Inc. stock attracts strong analyst attentionTrade Signal Summary & Weekly High Return Opportunities - thegnnews.com
Visual analytics tools that track PepGen Inc. performance2025 Big Picture & Fast Gaining Stock Reports - Newser
PepGen Inc (PEPG) Stock: A Year of Highs and Lows in the Market - investchronicle.com
FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of PepGen - Business Wire
Wedbush Has Bullish Forecast for PepGen FY2025 Earnings - Defense World
Is PepGen Inc. a speculative investmentGrowth Stock Safety Picks - kangso.co.kr
Faruqi & Faruqi Reminds PepGen Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of August 11, 2025PEPG - PR Newswire
Are Bears Losing Grip on PepGen Inc.Investment Plan With Growth Optimization Finalized - beatles.ru
SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of PepGen - TradingView
Pepgen Inc Stock (PEPG) Financials Data
Revenue
Net Income
Cash Flow
EPS
Pepgen Inc Stock (PEPG) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| McArthur James G | President and CEO |
Apr 17 '25 |
Buy |
1.35 |
10,000 |
13,550 |
113,913 |
| McArthur James G | President and CEO |
Apr 08 '25 |
Buy |
1.15 |
41,500 |
47,725 |
103,913 |
| DeLena Mary Beth | General Counsel |
Feb 26 '25 |
Sale |
1.68 |
1,432 |
2,406 |
1,568 |
| Donnelly Noel | Chief Financial Officer |
Feb 26 '25 |
Sale |
1.68 |
1,527 |
2,565 |
1,673 |
0.94%
1.72%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):